Pediatrix Medical (MD) Return on Capital Employed (2010 - 2026)

Pediatrix Medical has disclosed Return on Capital Employed across 17 years of filings, most recently posting 3.21% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 612.0% year-over-year to 3.21%; the TTM figure through Mar 2026 stood at 3.21% (up 612.0% YoY), while the FY2025 annual figure was 2.61%, up 653.0% from the prior year.
• Return on Capital Employed climbed to 3.21% in Q1 2026, from 2.58% in the prior quarter.
• Over the last five years, Return on Capital Employed for MD reached as high as 11.34% in Q3 2025 and fell as low as 13.2% in Q3 2024.
• The 5-year median for Return on Capital Employed is 7.88% (2023), against an average of 3.42%.
• Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 2108 bps — and 2025, when it soared 2453 bps.
• A 5-year view of Return on Capital Employed shows it stood at 9.03% in 2022, then plunged by 96 bps to 0.39% in 2023, then tumbled by 1152 bps to 4.09% in 2024, then surged by 163 bps to 2.58% in 2025, then increased by 24 bps to 3.21% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 3.21%, 2.58%, and 11.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.